Find policies, billing codes, payers, states, and providers
CPT 0822T: Clinical Staff Monitoring During Psychedelic Medication Therapy
CPT code 0822T designates hourly, in‑person monitoring and intervention by clinical staff under the direction of a physician or other qualified healthcare professional during a patient’s psychedelic medication therapy. The code captures concurrent staff support that addresses potential emotional and physiological issues arising during sessions and ensures patient safety. Nationally, this code is relevant as psychedelic-assisted treatments expand in clinical practice and payers consider coverage frameworks for associated staffing and supervision needs. Key payers in the landscape include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will learn what the code represents clinically and operationally, which payers are commonly considered in benchmarking and coverage discussions, and what to expect in terms of coding context and service setting. The publication provides benchmarks where available, summarizes recent policy considerations affecting coverage of psychedelic therapy support services, and outlines clinical context for accurate coding and billing of concurrent staff monitoring reported per hour. Data not available in the input is noted where applicable.
Customize your policy alerts
Sign up for cpt 0822T policy alerts
Get alerted when payer policies referencing 0822T are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 0822T describes a service in which clinical staff, under the direction of a physician or other qualified healthcare professional (QHP), provide continuous, in‑person monitoring and intervention during a patient's psychedelic medication therapy. This service is furnished concurrently with a first physician or other QHP and is reported per hour.
Service Type
- Clinical monitoring and intervention during psychedelic medication therapy (concurrent staff service)
Typical Site of Service
- Behavioral health or specialty treatment setting where psychedelic-assisted therapy is provided, including inpatient or outpatient psychiatric units and designated therapy clinics.